Posts Tagged: Commercialization
Dr. Geoff Fernie is developing a wearable technology that reminds first-line responders to wash their hands despite their busy schedules. This technology could significantly reduce the spread of Hospital-Acquired Infections (HAIs) including COVID19.
Interface Biologics's (IBI) antithrombogenic additive have been used in a new line of FDA-approved "breakthrough" dialysis products made by IBI's partner, Fresenius Medical Care.
Professor Milica Radisic (Institute of Biomaterials and Biomedical Engineering, Chemical Engineering), Professor Boyang Zhang (IBBME Alumni), and Dr. Yimu Zhao (Chemical Engineering, IBBME) had been awarded the 2019 Innovation & Commercialization Award by Tissue Engineering International & Regenerative Medicine Society (TERMIS).
This U of T Engineering innovation makes implants safer, and is attracting new investment to Toronto
Global chemical company Evonik will maintain presence in Toronto after acquiring part of U of T spinoff Interface Biologics, Inc.
Toronto-based entrepreneur Zaid Atto receives FACIT’s Ernsting Entrepreneurship Award to further develop his new device for safer and less invasive surgeries
Cohesys, a biomedical device startup that makes biodegradable ‘bone tape’ to help heal facial fractures, recently took home US$20,000 at an international competition.
U of T Engineering is partnering with Canada’s National Research Council (NRC) to create a national innovation hub focused on microfluidics.
Polumiros, co-founded by Kyle Battiston and Soror Sharifpoor, is developing a polymer to fill the cavities left in breast cancer patients following a lumpectomy.
U of T biomedical engineering professor receives UHN support to drive commercialization and entrepreneurship opportunities for students and hospital trainees.
Professor Paul Santerre is co-director of U of T's Health Innovation Hub (H2i), a campus-based accelerator involved with more than 40 startups this year.
Showing 1 - 10 of 33 results